Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review Giulio FortunaMassimo AriaJulie H. Schiavo Review 13 September 2017 Pages: 1523 - 1537
The prevalence of medication-related adverse events in inpatients—a systematic review and meta-analysis Outi LaatikainenJ. MiettunenM. Turpeinen Review 05 September 2017 Pages: 1539 - 1549
Regulatory experience of TOPS: an internet-based system to prevent healthy subjects from over-volunteering for UK clinical trials C. AllenG. FrancisM. Boyce Clinical Trial 15 September 2017 Pages: 1551 - 1555
Who is willing to participate in low-risk pragmatic clinical trials without consent? Rafael Dal-RéAntonio J. CarcasXavier Carné Clinical Trial Open access 12 September 2017 Pages: 1557 - 1563
Analysis of integrated clinical trial protocols in early phases of medicinal product development Kevin FruhnerGunther HartmannThomas Sudhop Clinical Trial Open access 18 September 2017 Pages: 1565 - 1577
Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects Carmen WalterBruno G. OertelJörn Lötsch Pharmacodynamics 02 September 2017 Pages: 1579 - 1587
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism A. B. Sanchez SpitmanD. J. A. R. MoesH. J. Guchelaar Pharmacogenetics Open access 28 August 2017 Pages: 1589 - 1598
Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration Xingang LiShusen SunZhigang Zhao Pharmacokinetics and Disposition 29 August 2017 Pages: 1599 - 1607
Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens Zoe OesterreicherIris MinichmayrMarkus Zeitlinger Pharmacokinetics and Disposition Open access 17 September 2017 Pages: 1609 - 1613
Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan Hsien-Feng LinKuan-Fu LiaoShih-Wei Lai Pharmacokinetics and Disposition 30 August 2017 Pages: 1615 - 1621
Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite Dorota DanielakMarta Karaźniewicz-ŁadaFranciszek Główka Pharmacokinetics and Disposition Open access 15 September 2017 Pages: 1623 - 1632
Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia L. M. J. SandersT. HortobágyiM. J. G. van Heuvelen Pharmacoepidemiology and Prescription Open access 18 September 2017 Pages: 1633 - 1642
Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database Takuya ImatohKimie SaiYoshiro Saito Pharmacoepidemiology and Prescription 22 August 2017 Pages: 1643 - 1653
Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients Antoine ParienteYohann MansiauxBernard Bégaud Pharmacoepidemiology and Prescription 02 September 2017 Pages: 1655 - 1663
Development and validation of a Medicines Comorbidity Index for older people Sujita W. NarayanPrasad S. Nishtala Pharmacoepidemiology and Prescription 11 September 2017 Pages: 1665 - 1672
Number of medications or number of diseases: what influences underprescribing? Eva Cedilnik GorupMarija Petek Šter Pharmacoepidemiology and Prescription 17 September 2017 Pages: 1673 - 1679
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study Endalkachew AdmassieLeanne ChalmersLuke R. Bereznicki Pharmacoepidemiology and Prescription 22 September 2017 Pages: 1681 - 1689